Changing the rules for doctors, patients and families: PGxPredict™:WARFARIN Test

PGxPredict:WARFARIN test predicts how individual patients will respond to warfarin, a well-established anti-clotting agent often prescribed after cardiovascular events such as heart attack and stroke, for prophylaxis of clot formation in the setting of major surgery, and for the treatment of other clotting disorders. By helping doctors quickly and accurately establish the correct dose, it may:

• Increase warfarin’s efficacy
• Reduce the risk of serious side effects, including life-threatening bleeding
• Help patients achieve faster recovery

In early 2008 the American Medical Association and several partners issued a personalized health care report on warfarin and genetic testing. The report notes that twenty-one percent of patients who receive anticoagulation therapy experience either major or minor bleeding events and that knowing a patient’s genotype may aid in initial warfarin dosing. The report can be viewed at the AMA website and printed versions can be ordered.

1-877-2-PGXHEALTH (877-274-9432)